Literature DB >> 6194559

The purification and manufacture of human interferons. Their promise is still not fulfilled, but now their genes have been isolated and cloned in E. coli. The bacteria are making interferon in quantity and the bacterial product is undergoing clinical trials.

S Pestka.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1983        PMID： 6194559

Source DB:  PubMed          Journal:  Sci Am        ISSN： 0036-8733            Impact factor:   2.142


× No keyword cloud information.
  5 in total

1.  Comparison of antiviral activities of cloned and native human interferons against herpes simplex virus types 1 and 2 and human cytomegalovirus.

Authors:  L E Rasmussen; P T Chen; T C Merigan
Journal:  Antimicrob Agents Chemother       Date:  1984-10       Impact factor: 5.191

Review 2.  Interferons in relapsing-remitting multiple sclerosis: are there benefits from long-term use?

Authors:  Oscar Fernández
Journal:  CNS Drugs       Date:  2004       Impact factor: 5.749

3.  Phase I study of escalating dose mitoxantrone in combination with alpha-2-interferon in patients with advanced solid tumors.

Authors:  G Gasparini; S Dal Fior; F Pozza; G A Panizzoni; S Favretto; D D Von Hoff
Journal:  Invest New Drugs       Date:  1991-08       Impact factor: 3.850

4.  Pulmonary deposition and clearance of aerosolized interferon.

Authors:  P R Wyde; S Z Wilson; M J Kramer; C S Sun; V Knight
Journal:  Antimicrob Agents Chemother       Date:  1984-06       Impact factor: 5.191

Review 5.  Interferons in multiple sclerosis. A review of the evidence.

Authors:  H S Panitch
Journal:  Drugs       Date:  1992-12       Impact factor: 9.546
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.